Core Points - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. and reminds investors of the October 10, 2025 deadline to seek the role of lead plaintiff in a federal securities class action [2][3] Allegations Against SelectQuote - The complaint alleges that SelectQuote and its executives violated federal securities laws by making false and misleading statements, including directing Medicare beneficiaries to plans that compensated SelectQuote the most, rather than providing unbiased comparisons [4] - SelectQuote is accused of receiving illegal kickbacks from health insurance companies to steer Medicare beneficiaries towards certain plans, which led to non-compliance with applicable laws and regulations [4][5] - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received tens of millions of dollars in illegal kickbacks and engaged in discriminatory practices against less profitable beneficiaries [5] Stock Market Reaction - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually heavy trading volume [5]

Core Points - TIAN RUIXIANG Holdings Ltd. has entered into a securities purchase agreement for the sale of 2,000,000 Class A ordinary shares and warrants to purchase an additional 4,000,000 shares at a price of $1.50 per share, resulting in gross proceeds of approximately $3 million [1][2] - The warrants will have an exercise price of $1.50 per share, are exercisable immediately upon issuance, and will expire five years after the initial exercise date [1] - The closing of the offering is expected around October 14, 2025, subject to customary closing conditions [1] Use of Proceeds - The net proceeds from the offering will be used for working capital and general corporate purposes [2] Regulatory Information - The offering is made pursuant to a registration statement on Form F-3, which was declared effective by the SEC on May 31, 2023 [3] - A final prospectus supplement and accompanying prospectus will be filed with the SEC and will be available on the SEC's website [3] Company Overview - TIAN RUIXIANG Holdings Ltd. is an insurance broker based in Beijing, China, distributing a variety of insurance products, including property and casualty insurance and other types such as health and life insurance [5]

Core Points - Arthur J. Gallagher & Co. will release its third quarter 2025 earnings after the market closes on October 30, 2025 [1] - J. Patrick Gallagher, Jr., Chairman and CEO, will host a conference call on the same day at 5:30 pm ET/4:30 pm CT [1] - The conference call will be broadcast live on Gallagher's website, with a replay available approximately two hours after the broadcast [2] Company Overview - Arthur J. Gallagher & Co. is a global insurance brokerage, risk management, and consulting services firm [2] - The company is headquartered in Rolling Meadows, Illinois, and operates in approximately 130 countries worldwide [2]

Core Viewpoint - Arthur J. Gallagher & Co. is positioned as a global specialty insurance broker, attracting investors amid macroeconomic uncertainties such as tariffs, interest rates, and inflation, as brokers can generate profits without the underwriting risks associated with insurance [1] Company Summary - Arthur J. Gallagher & Co. operates in the specialty insurance brokerage sector, which is increasingly appealing to investors looking for stability in uncertain economic conditions [1] Industry Summary - The insurance brokerage industry is seen as a safe haven for investors during times of economic stress, as it allows for profit generation without the direct risks of underwriting [1]

Group 1 - A shareholder has filed a class action lawsuit against SelectQuote, Inc. (NYSE: SLQT) on behalf of purchasers and acquirers of its securities during the class period from September 9, 2020, to May 1, 2025 [1] - SelectQuote operates as an insurance broker [1] - The Rosen Law Firm is investigating the allegations related to the lawsuit [1]

Core Insights - ClearBridge Investments released its third-quarter 2025 investor letter for the ClearBridge Dividend Strategy, highlighting strong stock market performance and gains from AI exposure, despite lagging behind the S&P 500 Index benchmark [1] Group 1: Company Performance - The third-quarter performance of ClearBridge Dividend Strategy was strong, although it underperformed the S&P 500 Index [1] - Marsh & McLennan Companies, Inc. (NYSE:MMC) had a one-month return of 2.55% but lost 10.11% over the last 52 weeks, closing at $203.84 per share with a market capitalization of $100.213 billion on October 7, 2025 [2] - ClearBridge initiated new positions in Marsh & McLennan and Old Dominion Freight Line, citing Marsh & McLennan as a high-quality compounder that is currently undervalued due to temporary pricing softness in the industry [3] Group 2: Investment Sentiment - Marsh & McLennan is not among the 30 most popular stocks among hedge funds, with 60 hedge fund portfolios holding the stock at the end of Q2 2025, an increase from 56 in the previous quarter [3] - While acknowledging Marsh & McLennan's potential, ClearBridge believes certain AI stocks present greater upside potential and lower downside risk [3]

As filed with the Securities and Exchange Commission on September 26, 2025. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Zhibao Technology Inc. (Exact name of Registrant as specified in its charter) Not Applicable Floor 3, Building 6, Wuxing Road, Lane 727 Pudong New Area, Shanghai 201204 Tel: +86 (21) -5089-6502 (Address, including zip code, and telephone number, including area code, of Registrant ...

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly violating the False Claims Act by directing Medicare beneficiaries to insurers that compensated the company the most, rather than providing unbiased comparisons of insurance plans [2][3]. Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote failed to disclose that it directed Medicare beneficiaries to plans based on compensation rather than quality [2]. - It is claimed that SelectQuote did not provide unbiased comparison shopping for Medicare Advantage plans and received illegal kickbacks from insurers [2]. - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to at least 2021 [3]. Group 2: Impact on Stock Price - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025 [3]. Group 3: Class Action Participation - Shareholders interested in participating as lead plaintiffs in the class action must file their papers by October 10, 2025 [4]. - Shareholders can remain absent class members and still be eligible for recovery without participating in the case [4]. Group 4: Company Background - Robbins LLP is a law firm recognized for its work in shareholder rights litigation, helping shareholders recover losses and improve corporate governance since 2002 [5].

Core Viewpoint - A class action lawsuit has been filed against SelectQuote, Inc. for allegedly receiving illegal kickbacks from health insurance companies and misleading investors about its business practices [6]. Allegation Details - The U.S. Department of Justice filed a complaint against SelectQuote, alleging that from 2016 to at least 2021, the company received "tens of millions of dollars" in illegal kickbacks for steering Medicare beneficiaries to specific insurance plans [6]. - The lawsuit claims that SelectQuote made materially false statements and failed to disclose adverse facts about its operations, including directing beneficiaries to plans that compensated the company the most, rather than providing unbiased comparisons [6]. Stock Impact - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [6]. Legal Process - Investors who purchased SelectQuote securities between September 9, 2020, and May 1, 2025, have until October 10, 2025, to apply to be appointed as lead plaintiff in the lawsuit [6].

Core Viewpoint - The article highlights the significance of insider buying as a potential indicator of a company's value and future performance, specifically focusing on Marsh & McLennan Companies Inc. (MMC) where insider buying was observed [1]. Insider Buying Details - Director Anthony Anderson invested $201,612.50 to purchase 1,000 shares of MMC at a price of $201.61 per share on July 30, 2025 [2]. - Current trading prices for MMC shares are approximately 3.3% lower than Anderson's purchase price, with shares available as low as $195.01 [2]. Stock Performance - MMC's 52-week trading range shows a low of $195.01 and a high of $248, with the last trade recorded at $196.63 [4]. - The shares are currently trading at -0.24% on the day [2]. Valuation and Profitability - The DividendRank report indicates that MMC shares exhibit attractive valuation and strong profitability metrics, making them appealing for dividend investors [4]. - The company has a strong quarterly dividend history and favorable long-term growth rates in key fundamental data points [4]. Dividend Information - MMC pays an annualized dividend of $3.6 per share, distributed quarterly, with the most recent dividend ex-date on October 2, 2025 [5]. - The report emphasizes the importance of studying a company's past dividend history to assess the likelihood of continued dividend payments [5].